Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edythe D London

Showing results (11-20 of 234) with videos related to

Pageof 24
Sort By:
Drug and Alcohol Dependence|July 18, 2009
Sustained attention in patients receiving and abstinent following methadone maintenance treatment for opiate dependence: performance and neuroimaging resultsJames Prosser, Edythe D London, Igor I Galynker
Pharmacology & Therapeutics|March 11, 2021
Targeting mGlu<sub>5</sub> for Methamphetamine Use DisorderJohannes Petzold, Karen K Szumlinski, Edythe D London
AIMS Neuroscience|March 10, 2017
The Cerebellum and Premenstrual Dysphoric DisorderAndrea J Rapkin, Steven M Berman, Edythe D London
International Journal of Psychiatry in Clinical Practice|October 15, 2019
Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosisMei Yang, Chuanqing Yang, Tiebang Liu, et al.
Drug and Alcohol Dependence|January 7, 2023
Reduced neural functional connectivity during working memory performance in methamphetamine use disorderLiam J Nestor, Dara G Ghahremani, Edythe D London
Handbook of Experimental Pharmacology|February 3, 2009
Magnetic resonance imaging studies of cigarette smokingAllen Azizian, John Monterosso, Joseph O'Neill, et al.
Archives of General Psychiatry|November 3, 2010
Neural correlates of affect processing and aggression in methamphetamine dependenceDoris E Payer, Matthew D Lieberman, Edythe D London
Journal of Substance Abuse Treatment|September 11, 2002
Incorporating brain research findings into standard treatment: an example using the Matrix ModelJeanne L Obert, Edythe D London, Richard A Rawson
Trials|December 12, 2018
Single high-dose buprenorphine for opioid craving during withdrawalJamshid Ahmadi, Mina Sefidfard Jahromi, Dara Ghahremani, et al.
Frontiers in Psychiatry|September 8, 2017
Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public HealthAviv M Weinstein, Paola Rosca, Liana Fattore, et al.
Pageof 24

Showing results (11-20 of 234) with videos related to

Sort By:
Pageof 24
Drug and Alcohol Dependence|July 18, 2009
Sustained attention in patients receiving and abstinent following methadone maintenance treatment for opiate dependence: performance and neuroimaging resultsJames Prosser, Edythe D London, Igor I Galynker
Pharmacology & Therapeutics|March 11, 2021
Targeting mGlu<sub>5</sub> for Methamphetamine Use DisorderJohannes Petzold, Karen K Szumlinski, Edythe D London
AIMS Neuroscience|March 10, 2017
The Cerebellum and Premenstrual Dysphoric DisorderAndrea J Rapkin, Steven M Berman, Edythe D London
International Journal of Psychiatry in Clinical Practice|October 15, 2019
Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosisMei Yang, Chuanqing Yang, Tiebang Liu, et al.
Drug and Alcohol Dependence|January 7, 2023
Reduced neural functional connectivity during working memory performance in methamphetamine use disorderLiam J Nestor, Dara G Ghahremani, Edythe D London
Handbook of Experimental Pharmacology|February 3, 2009
Magnetic resonance imaging studies of cigarette smokingAllen Azizian, John Monterosso, Joseph O'Neill, et al.
Archives of General Psychiatry|November 3, 2010
Neural correlates of affect processing and aggression in methamphetamine dependenceDoris E Payer, Matthew D Lieberman, Edythe D London
Journal of Substance Abuse Treatment|September 11, 2002
Incorporating brain research findings into standard treatment: an example using the Matrix ModelJeanne L Obert, Edythe D London, Richard A Rawson
Trials|December 12, 2018
Single high-dose buprenorphine for opioid craving during withdrawalJamshid Ahmadi, Mina Sefidfard Jahromi, Dara Ghahremani, et al.
Frontiers in Psychiatry|September 8, 2017
Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public HealthAviv M Weinstein, Paola Rosca, Liana Fattore, et al.
Pageof 24